Table 1 Clinical characteristic of epileptic patients
Epilepsy syndrome | TLE | XLE | IGE |
|---|---|---|---|
n | 409 | 290 | 519 |
Female/male | 90/319 | 51/239 | 110/409 |
Age (mean ± SD, years) | 33.2 ± 12.4 | 31.0 ± 10.9 | 30.8 ± 10.8 |
Epilepsy duration (mean ± SD, years) | 15.1 ± 9.8 | 19.2 ± 15.2 | 10.9 ± 11.2 |
Seizure frequency (mean ± SD, seizure/month) | 10.0 ± 12.4 | 19.3 ± 17.3 | 15.5 ± 11.3 |
Brain MRI (n, %) | |||
Normal | 316 (77.3) | 190(65.5) | 519 (100) |
Abnormal | 93 (22.7) | 100 (34.5) | 0 |
Side of epilepsy (n, %) | |||
Left | 119 (29.1) | 78 (26.9) | 136 (26.2) |
Right | 192 (46.9) | 76 (26.2) | 166 (32.0) |
Unidentified | 98 (24.0) | 136 (46.9) | 217 (41.8) |
Anti-epileptic drugs (n, %) | |||
None | 7 (1.7) | 5 (1.7) | 7 (1.4) |
Mono-drug | 37 (9.0) | 39 (13.4) | 76 (14.7) |
Poly-drug | 365 (89.2) | 246 (84.9) | 436 (84.0) |
Refractory epilepsy (n, %) | 377 (92.2) | 268 (92.4) | 468 (90.1) |